Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases

Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

(2020) Cong Ye et al.   ANNALS OF THE RHEUMATIC DISEASES

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2020) Milena Gianfrancesco et al.   ANNALS OF THE RHEUMATIC DISEASES

Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region

(2020) Roberta L. DeBiasi et al.   JOURNAL OF PEDIATRICS

Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs

(2020) Giovanni Filocamo et al.   JOURNAL OF RHEUMATOLOGY

SARS-CoV-2 Infection in Children

(2020) Xiaoxia Lu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel coronavirus infection in children outside of Wuhan, China

(2020) Qinxue Shen et al.   PEDIATRIC PULMONOLOGY

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19

(2020) Oya Koker et al.   RHEUMATOLOGY INTERNATIONAL

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

(2020) Xabier Michelena et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 1

(2020) Dawn M. Wahezi et al.   Arthritis & Rheumatology

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

(2020) Matthew C. Woodruff et al.   NATURE IMMUNOLOGY

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

(2020) Jesús Loarce-Martos et al.   RHEUMATOLOGY INTERNATIONAL

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members

(2020) Achille Marino et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry

(2020) Milena A. Gianfrancesco et al.   Arthritis & Rheumatology

Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies

(2013) A Danza et al.   LUPUS

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

(2012) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM